A comprehensive view of Kenvue Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
In-Cosmetics Global Awards, sponsored by Kenvue, see record number of entries for Best Active Ingredient and Best Functional Ingredient categories; dsm-firmenich, Mibelle Biochemistry and Evonik among winners
Published:
May 06, 2024
by CosmeticsDesign.com (US)
|
Kenvue's Global Head of R&D - Skin Health & Beauty highlights sustainability, consumer need and efficacy as key trends in beauty and personal care industry at In-Cosmetics Global; takeaways confirm focus on ingredient formulation to meet consumer needs
Published:
May 02, 2024
by CosmeticsDesign.com (US)
|
J&J spinoff Kenvue, maker of Benadryl, Tylenol, other OTC products, to open a new headquarters in Summit, New Jersey with over 3,000 employees; the facility to include offices, research and development centers and an innovation lab on the 46-acre campus
Published:
April 26, 2024
by The Record
|
Kenvue declares quarterly cash dividend of US$0.20, payable on May 22
Published:
April 25, 2024
by Kenvue Inc.
|
Illinois jury awards US$45M in damages in mesothelioma case against Johnson & Johnson, Kenvue; jury in the Circuit Court of Cook County in Chicago concluded lifelong use of talcum-based baby powder caused a woman's mesothelioma and death
Published:
April 23, 2024
by Business Wire
|
Ask us about our Health Care Sector market view